Publicacións en colaboración con investigadores/as de University Health Network (2)

2022

  1. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

    Kidney International, Vol. 101, Núm. 1, pp. 174-184

2012

  1. A missense mutation in PKD1 attenuates the severity of renal disease

    Kidney International, Vol. 81, Núm. 4, pp. 412-417